Details of a new drug that aims to treat the underlying causes of obesity were presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September).
from Medical Xpress - latest medical and health news stories https://ift.tt/67EPFRM
